trending Market Intelligence /marketintelligence/en/news-insights/trending/ikfak80yi9qcpzs474ftbg2 content esgSubNav
In This List

Bellicum Pharmaceuticals adds former Pfizer exec to board

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Bellicum Pharmaceuticals adds former Pfizer exec to board

Houston-based biotech company Bellicum Pharmaceuticals Inc. appointed Edmund Harrigan to its board.

Harrigan most recently served as the senior vice president of worldwide safety and regulatory at Pfizer Inc.

He has 28 years of industry experience in clinical development, regulatory affairs and business development.

Bellicum CEO Rick Fair said Harrigan's addition will be "instrumental" as the company develops treatments for cancers and rare blood disorders.